Biomedical Research Networking Center in Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN) & Jesus Usón Minimally Invasive Surgery Center (JUMISC) 20 May Researchers from INMA and NANBIOSIS have developed ultrasmall platinum nanoparticles that significantly boost radiotherapy effectiveness against cancer. Zaragoza, May 2026 — Researchers from the Aragon Nanoscience and Materials Institute (INMA), together with collaborators from Instituto de Salud Carlos III, Spanish National Cancer[...] 19 May NANBIOSIS opens in June the 2nd Competitive Open Call of 2026 for our “Cutting-Edge Biomedical Solutions” and services. On January we opened our 1st Open Call of 2026, and it was about time to introduce you to the second ca[...] 20 May Researchers from INMA and NANBIOSIS have developed ultrasmall platinum nanoparticles that significantly boost radiotherapy effectiveness against cancer. Zaragoza, May 2026 — Researchers from the Aragon Nanoscience and Materials Institute (INMA), together with collaborators from Instituto de Salud Carlos III, Spanish National Cancer[...] 19 May NANBIOSIS opens in June the 2nd Competitive Open Call of 2026 for our “Cutting-Edge Biomedical Solutions” and services. On January we opened our 1st Open Call of 2026, and it was about time to introduce you to the second ca[...] 20 May Researchers from INMA and NANBIOSIS have developed ultrasmall platinum nanoparticles that significantly boost radiotherapy effectiveness against cancer. Zaragoza, May 2026 — Researchers from the Aragon Nanoscience and Materials Institute (INMA), together with collaborators from Instituto de Salud Carlos III, Spanish National Cancer[...] 19 May NANBIOSIS opens in June the 2nd Competitive Open Call of 2026 for our “Cutting-Edge Biomedical Solutions” and services. On January we opened our 1st Open Call of 2026, and it was about time to introduce you to the second ca[...]Welcome to Nanbiosis
Lorem ipsum dolor sit amet, consectetur adipisicing elit. Ipsa dicta hic cupiditate dolor, aspernatur, blanditiis aperiam omnis corporis voluptatibus aut nihil a quis. Accusamus, numquam, accusantium ipsum itaque quidem expedita. Lorem ipsum dolor sit amet, consectetur adipisicing elit.Latest From the Blog

Platinum Nanoparticles Boost Radiotherapy Effectiveness Against Cancer

Ready your proposals: Our Open Call starts on June

Platinum Nanoparticles Boost Radiotherapy Effectiveness Against Cancer

Ready your proposals: Our Open Call starts on June

Platinum Nanoparticles Boost Radiotherapy Effectiveness Against Cancer

Ready your proposals: Our Open Call starts on June
Units of Nanbiosis

About Nanbiosis
Responsive Design
HiDPi Ready
Drag’n’drop builder





